• Title of article

    Mechanism of oral tolerance induction to therapeutic proteins

  • Author/Authors

    Wang، نويسنده , , Xiaomei and Sherman، نويسنده , , Alexandra and Liao، نويسنده , , Gongxian and Leong، نويسنده , , Kam W. and Daniell، نويسنده , , Henry and Terhorst، نويسنده , , Cox and Herzog، نويسنده , , Roland W.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2013
  • Pages
    15
  • From page
    759
  • To page
    773
  • Abstract
    Oral tolerance is defined as the specific suppression of humoral and/or cellular immune responses to an antigen by administration of the same antigen through the oral route. Due to its absence of toxicity, easy administration, and antigen specificity, oral tolerance is a very attractive approach to prevent unwanted immune responses that cause a variety of diseases or that complicate treatment of a disease. Many researchers have induced oral tolerance to efficiently treat autoimmune and inflammatory diseases in different animal models. However, clinical trials yielded limited success. Thus, understanding the mechanisms of oral tolerance induction to therapeutic proteins is critical for paving the way for clinical development of oral tolerance protocols. This review will summarize progress on understanding the major underlying tolerance mechanisms and contributors, including antigen presenting cells, regulatory T cells, cytokines, and signaling pathways. Potential applications, examples for therapeutic proteins and disease targets, and recent developments in delivery methods are discussed.
  • Keywords
    TGF-? , Th3 , Nanoparticles , Tr1 , Oral delivery , transgenic plants , Protein antigen , dendritic cells , Treg , IL-10 , oral tolerance
  • Journal title
    Advanced Drug Delivery Reviews
  • Serial Year
    2013
  • Journal title
    Advanced Drug Delivery Reviews
  • Record number

    1763727